TY - JOUR
T1 - The role of cytokines in radiation oncology.
AU - Hallahan, D. E.
AU - Haimovitz-Friedman, A.
AU - Kufe, D. W.
AU - Fuks, Z.
AU - Weichselbaum, R. R.
PY - 1993/1/1
Y1 - 1993/1/1
N2 - Cytokine induction following ionizing radiation exposure occurs through transcriptional activation in specific proteins studied to date. This process can be blocked by inhibition of radiation-induced signaling pathways, which may potentially modify certain deleterious effects of radiotherapy, e.g., effects related to production of TNF or TGF-beta. bFGF is another radiation-inducible protein that may participate in repair and protection of irradiated endothelial cells following a complex interaction with cellular receptors. The cytokines such as IL-6, TNF, and IL-1 may be useful to protect hematopoietic cells from radiation, while TNF may enhance the killing of tumor cells. Our understanding of cytokine/radiation interactions is only beginning to be understood, but knowledge of the biology of these interactions may prove clinically useful.
AB - Cytokine induction following ionizing radiation exposure occurs through transcriptional activation in specific proteins studied to date. This process can be blocked by inhibition of radiation-induced signaling pathways, which may potentially modify certain deleterious effects of radiotherapy, e.g., effects related to production of TNF or TGF-beta. bFGF is another radiation-inducible protein that may participate in repair and protection of irradiated endothelial cells following a complex interaction with cellular receptors. The cytokines such as IL-6, TNF, and IL-1 may be useful to protect hematopoietic cells from radiation, while TNF may enhance the killing of tumor cells. Our understanding of cytokine/radiation interactions is only beginning to be understood, but knowledge of the biology of these interactions may prove clinically useful.
UR - http://www.scopus.com/inward/record.url?scp=0027346146&partnerID=8YFLogxK
M3 - Review article
C2 - 8505057
AN - SCOPUS:0027346146
SN - 0883-5896
SP - 71
EP - 80
JO - Important advances in oncology
JF - Important advances in oncology
ER -